E. Genovesi

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy

M. Dieci, P. Conte, V. Guarneri, 2021, NPJ breast cancer.

Stakeholder experiences, attitudes and perspectives on inclusive education for children with developmental disabilities in sub-Saharan Africa: A systematic review of qualitative studies

R. Hoekstra, C. Hanlon, L. Nugent, 2021, Autism : the international journal of research and practice.

HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment

M. Fassan, M. Dieci, P. Conte, 2022, npj Breast Cancer.

Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer

M. Dieci, P. Conte, G. Faggioni, 2020, The oncologist.

Evolution of HER2-low expression from primary to recurrent breast cancer

M. Fassan, M. Dieci, P. Conte, 2021, NPJ breast cancer.

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy

M. Dieci, P. Conte, V. Guarneri, 2021, npj Breast Cancer.

Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation

M. Fassan, M. Dieci, F. Piacentini, 2022, British Journal of Cancer.

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

M. Fassan, M. Dieci, P. Conte, 2021, NPJ breast cancer.